Biosmart Coltd Stock Gross Profit
| 038460 Stock | KRW 5,870 10.00 0.17% |
BioSmart CoLtd fundamentals help investors to digest information that contributes to BioSmart CoLtd's financial success or failures. It also enables traders to predict the movement of BioSmart Stock. The fundamental analysis module provides a way to measure BioSmart CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioSmart CoLtd stock.
BioSmart |
BioSmart CoLtd Company Gross Profit Analysis
BioSmart CoLtd's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current BioSmart CoLtd Gross Profit | 58.91 B |
Most of BioSmart CoLtd's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioSmart CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, BioSmart CoLtd reported 58.91 B of gross profit. This is much higher than that of the Technology Hardware, Storage & Peripherals sector and significantly higher than that of the Information Technology industry. The gross profit for all Republic of Korea stocks is notably lower than that of the firm.
BioSmart Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioSmart CoLtd's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioSmart CoLtd could also be used in its relative valuation, which is a method of valuing BioSmart CoLtd by comparing valuation metrics of similar companies.BioSmart CoLtd is currently under evaluation in gross profit category among related companies.
BioSmart Fundamentals
| Return On Equity | 2.28 | |||
| Return On Asset | 0.0086 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 153.4 B | |||
| Shares Outstanding | 19.98 M | |||
| Shares Owned By Insiders | 23.20 % | |||
| Shares Owned By Institutions | 1.07 % | |||
| Price To Earning | 79.80 X | |||
| Price To Sales | 0.33 X | |||
| Revenue | 189.18 B | |||
| Gross Profit | 58.91 B | |||
| EBITDA | 8.09 B | |||
| Net Income | 633.79 M | |||
| Cash And Equivalents | 433.16 M | |||
| Cash Per Share | 966.69 X | |||
| Total Debt | 33.07 B | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 1.50 X | |||
| Cash Flow From Operations | 2.33 B | |||
| Number Of Employees | 164 | |||
| Beta | 1.02 | |||
| Market Capitalization | 73.22 B | |||
| Total Asset | 225.85 B | |||
| Retained Earnings | 8.06 B | |||
| Working Capital | 6.46 B | |||
| Current Asset | 22.12 B | |||
| Current Liabilities | 15.66 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 225.85 B |
About BioSmart CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioSmart CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSmart CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSmart CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioSmart CoLtd in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioSmart CoLtd's short interest history, or implied volatility extrapolated from BioSmart CoLtd options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioSmart CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the BioSmart CoLtd information on this page should be used as a complementary analysis to other BioSmart CoLtd's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for BioSmart Stock analysis
When running BioSmart CoLtd's price analysis, check to measure BioSmart CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioSmart CoLtd is operating at the current time. Most of BioSmart CoLtd's value examination focuses on studying past and present price action to predict the probability of BioSmart CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioSmart CoLtd's price. Additionally, you may evaluate how the addition of BioSmart CoLtd to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |